Presentation is loading. Please wait.

Presentation is loading. Please wait.

Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006.

Similar presentations


Presentation on theme: "Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006."— Presentation transcript:

1 Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006

2 AIM represents 64 immunization projects which receive Section 317 immunization grants from CDC 50 states, 8 territories, 6 cities AIM members involved in every aspect of program: VFC, vaccine distribution, provider and consumer education, partnerships, purchases, etc.

3 Implementation of HPV Vaccine: Challenges Financing Infrastructure support Policy implications: School Requirement?

4 Financing Uninsured (age 9-18) COVERED (age 19-26) LIMITED COVERAGE Insured COVERED ? UndersinsuredLIMITED COVERAGE –317 funding –State/local funding

5 Grantee plans for HPV implementation for underinsured in PUBLIC settings AIM HPV Implementation Survey, September 2006, N = 27

6 What funds will be used to purchase vaccine if you are planning to provide vaccine for underinsured populations in PUBLIC settings? AIM HPV Implementation Survey, September 2006, N= 27

7 Grantee plans for HPV implementation for underinsured in PRIVATE settings AIM HPV Implementation Survey, September 2006, N = 27

8 What funds will be used to purchase vaccine if you are planning to provide vaccine for underinsured populations in PRIVATE settings? AIM HPV Implementation Survey, September 2006, N= 24

9 Grantee plans for HPV implementation for females aged 19-26 years old. Check all that apply. AIM HPV Implementation Survey, September 2006, N= 25

10 Infrastructure Support Adolescents: new and different strategies Non-traditional providers Medical homes? Consent issues New partners Majority of states: no full time adolescent immunization staff

11 School Requirements Successful public health strategy for preventing spread of disease in schools Assurance of high coverage rates in school-aged population Collaboration with schools: –Enforcement –Documentation

12 Should School Requirements be used to implement new vaccines? Risks vs. Benefits AIM believes school requirements should be used cautiously after sufficient implementation period –Supply-- Safety –Registries-- Acceptance –Burden on schools

13 THANK YOU. AIM Position Statement on School Vaccine Requirements available at www.immunizationmanagers.org www.immunizationmanagers.org Claire Hannan, MPH Executive Director, AIM (301) 424-5439 channan@astho.org


Download ppt "Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006."

Similar presentations


Ads by Google